Griffith University’s Institute for Glycomics has received a $5 million philanthropic donation from the International Leducq Foundation to further the development of a Strep A vaccine.
A team of international scientists from Griffith University and the University of Alberta are about to start human clinical trials for a Strep A vaccine they hope will induce long-lasting immunity against the deadly pathogen which kills more than 500,000 people each year.
Painful monthly penicillin injections could be a thing of the past with Griffith University researchers, in collaboration with researchers at...
Strep A, which can lead to serious illness and death if untreated, should be recognised as a Neglected Tropical Disease...
Five Griffith University research projects have been awarded a total of $916,000 in funding by the Cancer Council Queensland and...
Griffith University will partner with a Chinese pharmaceutical for a new vaccine that has enormous potential to help millions. Clinical trials of the new, needle-free vaccine is targeted at Streptococcus A infection, the cause of strep throat and rheumatic heart disease and many other illnesses.
Strep A (Streptococcus pyogenes) is a major cause of infection-related deaths, leading to over 500,000 fatalities annually. Developing countries, Indigenous populations, and vulnerable groups face the greatest risks. A potential vaccine, developed by Professor Michael Good's team at Griffith University, is undergoing human trials and shows promise in fighting multiple Strep A strains.
As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria.
Griffith University Institute for Glycomics researchers are closer to the development of a new vaccine aimed at preventing the deadly Streptococcus A (Strep A), which kills more than 500,000 people globally per year.
Griffith University’s Institute for Glycomics has been awarded $2.66 million in Ideas Grant funding from the National Health and Medical...
